Aerocrine AB announced that Health Care Service Corp. will begin covering FeNO testing for asthma diagnosis and management effective April 1. According to a release, Aerocrine has received ...

This case study has been carried out by Carol Stonham MBE, a Medical Advisory Board member. Carol has worked as a registered nurse since 1986, shifting from acute hospital care to primary care by 1990 ...

Affecting approximately 262 million people worldwide, asthma is a chronic condition of the lungs that causes airway inflammation. 1. Typical symptoms include: Breathlessness; Whee ...

MORRISVILLE, N.C.--(BUSINESS WIRE)--Circassia Inc. announced today that it has successfully engaged with major primary care national sales partners to expand the distribution of NIOX VERO®, its FeNO ...

Nov. 17, 2021 – In its latest clinical practice guideline on evaluation and treatment of asthma, an American Thoracic Society expert guidelines panel has addressed the use of fractional exhaled nitric ...

Aerocrine AB has announced that Health Care Service Corp. will begin covering FeNO testing for asthma diagnosis and management effective April 1. In a release, the Company said that it has received ...

IS LUNG HEALTH DAY, THOUGH MANY OF US TAKE BREATHING FOR GRANTED, MILLIONS OF PEOPLE STRUGGLE GETTING ENOUGH AIR DUE TO ASTHMA CONDITION THAT CAN BE DEADLY. AN ESTIMATED 262 MILLION PEOPLE WORLDWIDE ...

Please provide your email address to receive an email when new articles are posted on . Fractional exhaled nitric oxide testing is beneficial and is recommended in addition to usual care in patients ...

Aerocrine, Inc. announced the following scientific abstract, Characterization of Allergic Airway Inflammation in Patients with COPD using Fractional exhaled Nitric Oxide Level (FeNO)s, presented at ...

Rochester, MN, December 21, 2017 - Although about 24 million Americans are diagnosed with asthma every year, there is no single test that can diagnose the disease. Common symptoms, such as shortness ...